Cryoport Inc logo

CYRXCryoport Inc

NASDAQ · Industrials · Integrated Freight & Logistics

$15.93

+$0.38 (+2.44%)

Cryoport Inc (CYRX) is a integrated freight & logistics company listed on NASDAQ. It is led by Jerrell W. Shelton, based in 112 Westwood Place, Brentwood, TN, United States, 37027, with about 1,090 employees. Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide. The company's Life Sciences Services segment provides temperature-controlled logistics and cryogenic biostorage within the life science industry. Its Life Sciences Products segment offers cryogenic freezers, cryogenic dewars, and accessories within the life science industry through direct sales or a distribution network. The company's products include Cryoport Express Shippers; Cryoport ELITE Shippers; Cryoport Express Cryogenic HV3 Shipping System; Smartpak II Condition Monitoring System and Tec4Med; and Cryoport accessories. It also provides Cryoport BioStorage/Bioservices, such as CRYOGENE, a biostorage solution for the provision of pre-clinical temperature-controlled biological materials management services; and Cryoport Systems Bioservices, including controlled temperature storage, kitting, labelling, fulfillment, sample management, drug return, and Qualified Person drug product release. In addition, the company offers IntegriCell services that comprise apheresis/leukapheresis collection, cryoshuttle transportation, cryo-process optimization, and cryopreservation services; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; CRYOPDP, a temperature-controlled logistics solution; MVE Biological Solutions' Fusion cryogenic system, a self-sustaining cryogenic freezer; and Vario cryogenic system, a cryogenic freezer system. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. The company was founded in 1999 and is based in Brentwood, Tennessee.

Latest reported CYRX revenue for 2025-09-30 was $44.2M. Net income was $89.9M. Revenue was down 2.7% from 2025-06-30 to 2025-09-30. CYRX currently screens at market cap $365.5M.

Use this CYRX page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the CYRX quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the CYRX SEC filings page. Lician reads the product cache first so this HTML stays unique to Cryoport Inc even when a live quote feed is slow.

About Cryoport Inc

Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide. The company's Life Sciences Services segment provides temperature-controlled logistics and cryogenic biostorage within the life science industry. Its Life Sciences Products segment offers cryogenic freezers, cryogenic dewars, and accessories within the life science industry through direct sales or a distribution network. The company's products include Cryoport Express Shippers; Cryoport ELITE Shippers; Cryoport Express Cryogenic HV3 Shipping System; Smartpak II Condition Monitoring System and Tec4Med; and Cryoport accessories. It also provides Cryoport BioStorage/Bioservices, such as CRYOGENE, a biostorage solution for the provision of pre-clinical temperature-controlled biological materials management services; and Cryoport Systems Bioservices, including controlled temperature storage, kitting, labelling, fulfillment, sample management, drug return, and Qualified Person drug product release. In addition, the company offers IntegriCell services that comprise apheresis/leukapheresis collection, cryoshuttle transportation, cryo-process optimization, and cryopreservation services; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; CRYOPDP, a temperature-controlled logistics solution; MVE Biological Solutions' Fusion cryogenic system, a self-sustaining cryogenic freezer; and Vario cryogenic system, a cryogenic freezer system. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. The company was founded in 1999 and is based in Brentwood, Tennessee.

CYRX Key Statistics

Market Cap

$365.50M

Volume

158,384

Previous Close

$16.34

Day Range

$16.42$16.94

00

EPS

-$2.49

Revenue

$228.38M

Net Income

-$114.76M

Gross Profit

$0.00

Free Cash Flow

$0.00

Revenue Growth

-2.1%

Profit Margin

-50.2%

Employees

1,090

CYRX Financials

Annual income statement in USD. Latest reported periods first.

CYRX annual income statement across FY2024, FY2023, FY2022
LineFY2024FY2023FY2022
Revenue$228.38M$233.25M$237.28M
Cost of Revenue$0.00$0.00$0.00
Gross Profit$0.00$0.00$0.00
Operating Income$0.00$0.00$0.00
Net Income-$114.76M-$99.59M-$37.33M
EPS (Diluted)-$2.49-$2.21-$0.24

Total Assets

$703.49M

Total Debt

$0.00

Shareholders' Equity

$0.00

Cash & Equivalents

$45.29M

Operating Cash Flow

-$16.32M

Free Cash Flow

$0.00

Cryoport Inc Company Information

Chairman, President & CEO
Jerrell W. Shelton
Headquarters
112 Westwood Place, Brentwood, TN, United States, 37027
Phone
949 470 2300
IPO / Founded
2005-03-15
Industry
Integrated Freight & Logistics
Data Updated:

Upcoming Events for CYRX